# ClinicalTrials.gov record NCT00434772

> PeptideScanner retained ClinicalTrials.gov record NCT00434772 at 2026-07-30T22:26:45.006Z. Its registry update date was 2009-05-28, and PeptideScanner's reviewed identity mapping was glucagon.

- Evidence object: `story:clinicaltrials-gov-nct00434772-glucagon:v1`
- Evidence domain: Clinical trials
- Date in source: 2009-05-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00434772-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00434772-glucagon-v1.json
- Content SHA-256: `963878119ccd6efdc3211a0e19f928cb706c61e41c4d37dc1b9ad41213a77052`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00434772 ([`ctg-observation-nct00434772-2009-05-28-b81e40d037b6`](#source-ctg-observation-nct00434772-2009-05-28-b81e40d037b6))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00434772 at 2026-07-30T22:26:45.006Z. Its registry update date was 2009-05-28, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct00434772-2009-05-28-b81e40d037b6`](#source-ctg-observation-nct00434772-2009-05-28-b81e40d037b6))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00434772 at 2026-07-30T22:26:45.006Z. Its registry update date was 2009-05-28, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct00434772-2009-05-28-b81e40d037b6`](#source-ctg-observation-nct00434772-2009-05-28-b81e40d037b6))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00434772-2009-05-28-b81e40d037b6`](#source-ctg-observation-nct00434772-2009-05-28-b81e40d037b6))

## Sources

<a id="source-ctg-observation-nct00434772-2009-05-28-b81e40d037b6"></a>
- **ClinicalTrials.gov record NCT00434772 · retained source version 2009-05-28:b81e40d037b6354da37a8f3ced86cdc25ebd611cad7844f84a99ce1926713b9d** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00434772) (`ctg-observation-nct00434772-2009-05-28-b81e40d037b6`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00434772." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00434772-glucagon-v1.json SHA-256: 963878119ccd6efdc3211a0e19f928cb706c61e41c4d37dc1b9ad41213a77052.